Details
Stereochemistry | ACHIRAL |
Molecular Formula | C2H8N2 |
Molecular Weight | 60.0983 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NCCN
InChI
InChIKey=PIICEJLVQHRZGT-UHFFFAOYSA-N
InChI=1S/C2H8N2/c3-1-2-4/h1-4H2
Molecular Formula | C2H8N2 |
Molecular Weight | 60.0983 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Ethylenediamine is a strongly basic amine useful as a building block in chemical synthesis. It is used as a solvent to dissolve proteins such as albumins, casein and in medicine to stabilize aminophylline when used in injections. Ethylenediamine is used in manufacture of chelating agents (EDTA), epoxy curing agents, dimethylolethylene-urea resins, emulsifying agents, textile lubricants, antifreeze inhibitor. It is also involved in the manufacture of many industrial chemicals and forms derivatives with carboxylic acids, nitriles, alcohols, alkylating agents, carbon disulfide, aldehydes and ketones. It is a basic building block to prepare heterocyclic compound such as imidazolidines.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Effect of Na2H2EDTA on the viability of rats' organism during hypothermia]. | 2001 |
|
Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. | 2001 |
|
Synthesis, evaluation and structure-activity relationships of 5-alkyl-2,3-dihydroimidazo[1,2-c] quinazoline, 2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-thiones and their oxo-analogues as new potential bronchodilators. | 2001 |
|
Atrial natriuretic peptide infusion and nitric oxide inhalation in patients with acute respiratory distress syndrome. | 2001 |
|
Reduction of dioxygen by a dimanganese unit bonded inside a cavity provided by a pyrrole-based dinucleating ligand. | 2001 Apr 1 |
|
Hydrogen-bonded adducts of ferrocene-1,1'-diylbis(diphenylmethanol): monomeric and dimeric 1:1 adducts with 1,2-bis(4-pyridyl)ethane and 1,2-diaminoethane. | 2001 Aug |
|
[H3N(CH2)2NH3]0.5[BePO4], a beryllophosphate analogue of aluminosilicate zeolite gismondine. | 2001 Aug |
|
Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. | 2001 Aug |
|
Synthesis and structure of [K(+)-(2,2)diaza-[18]-crown-6][K3Ge9]-2ethylenediamine: stabilization of the two-dimensional layer (2)(infinity)[K3Ge9(1-)]. | 2001 Aug 27 |
|
Enzymatic properties of sialic acid binding lectin from Rana catesbeiana modified with a water-soluble carbodiimide in the presence of various nucleophiles. | 2001 Dec |
|
Synthesis of 1-(3-aminopropyl)-4-phenyl-1,2,4-triazolin-5-one and 1-(3-aminopropyl)-3,4-diphenyl-1,2,4-triazolin-5-one. | 2001 Jan-Feb |
|
Behaviour of 2-substituted 1,3-indandiones towards aldimines. | 2001 Jan-Feb |
|
[Effect of calcium ion level in blood on physiological functions in rat subjected to immersion hypothermia]. | 2001 Jul |
|
Preparation of a ribonucleic acid-(polyamidoamine)-(zirconia-urea-formaldehyde resin) high-performance liquid affinity chromatographic stationary phase. | 2001 Jul |
|
Ion chromatographic determination of calcium and magnesium cations in human saliva and urine with a piezoelectric detector. | 2001 Jul |
|
An HPTLC method for the determination and the purity control of ciprofloxacin HCl in coated tablets. | 2001 Jul |
|
catena-Poly[dibromozinc(II)-mu-ethylenediamine-N:N']: resolution of structural anomalies resulting from the interpretation of vibrational spectra. | 2001 Jun |
|
Solid-phase synthesis of chiral stationary phases based on 2,4,5,6-tetrachloro-1,3-dicyanobenzene derivatives spaced from N-3,5-dinitrobenzoyl alpha-amino acids: comparative study of their resolution efficacy. | 2001 Jun |
|
Isolation and identification of clozapine metabolites in patient urine. | 2001 Jun |
|
Biodegradability of ethylenediamine-based complexing agents. | 2001 Jun |
|
Development of an ELISA to measure soluble CD163 in biological fluids. | 2001 Jun 1 |
|
Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patients. | 2001 Mar |
|
Rb(4)Hg(5)(Te(2))(2)(Te(3))(2)Te(3), [Zn(en)3](4)In(16)(Te2)4(Te3)Te22, and K2Cu2(Te2)(Te3): novel metal polytellurides with unusual metal-tellurium coordination. | 2001 Mar 12 |
|
Structures of a tetradentate ferrocenyl ligand and its oxorhenium(V) complex in solution and in the solid state. | 2001 Mar 12 |
|
Macrochelation, cyclometallation and G-quartet formation: N3- and C8-bound PdII complexes of adenine and guanine. | 2001 Mar 16 |
|
Chemoenzymatic synthesis of sucrose-containing aromatic polymers. | 2001 Mar 5 |
|
Chirality inversion in the bilirubin molecular exciton. | 2001 May 15 |
|
Template synthesis of a tetraazamacrocyclic ligand with two pendant pyridinyl groups: properties of the isomers of the metal-free ligand and of their first-row transition metal compounds. | 2001 May 7 |
|
Plane-wave density functional theoretic study of formation of clay-polymer nanocomposite materials by self-catalyzed in situ intercalative polymerization. | 2001 Nov 28 |
|
Gold-gold interactions as crystal engineering design elements in heterobimetallic coordination polymers. | 2001 Nov 5 |
|
Synthesis and antifungal activity of 3,3'-ethylenebis(5-alkyl-1,3,5-thiadiazine-2-thiones). | 2001 Oct |
|
Polar nitrogen compounds and their behaviour in the drinking water treatment process. | 2001 Oct |
|
Predictive value of chromatin decondensation in vitro on fertilization rate after intracytoplasmic sperm injection (ICSI). | 2001 Oct |
|
Effect of modification of the carboxyl groups of the sialic acid binding lectin from bullfrog (Rana catesbeiana) oocyte on anti-tumor activity. | 2001 Sep |
|
Aminoethylethanolamine: a new allergen in cosmetics? | 2001 Sep |
|
Syntheses, vibrational spectra, and theoretical studies of the adamantanoid Sn(4)Ch(10)(4-) (Ch = Se, Te) anions: X-ray crystal structures of [18-crown-6-K](4)[Sn4Se10]*5en and [18-crown-6-K](4)[Sn4Te10]*3en*2THF. | 2001 Sep 10 |
|
[Occupational asthma due to amines]. | 2002 Feb |
|
c-erbB-2 is not a major factor in the development of colorectal cancer. | 2002 Feb 12 |
|
Structure-directing coordination template effect of ethylenediamine in formations of ZnS and ZnSe nanocrystallites via solvothermal route. | 2002 Feb 25 |
|
Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptide. | 2002 Jan |
|
Optimization of urease immobilization onto non-porous HEMA incorporated poly(EGDMA) microbeads and estimation of kinetic parameters. | 2002 Jan |
|
Galactosylated alginate as a scaffold for hepatocytes entrapment. | 2002 Jan |
|
Syntheses, crystal structures, and density functional theory calculations of the closo-[1-M(CO)(3)(eta(4)-E(9))](4-) (E = Sn, Pb; M = Mo, W) cluster anions and solution NMR spectroscopic characterization of [1-M(CO)(3)(eta(4)-Sn(9))](4-) (M = Cr, Mo, W). | 2002 Jan 14 |
|
Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum. | 2002 Jan 2 |
|
Development of preparation methods for and insights obtained from atomic force microscopy of fluid spaces in cortical bone. | 2002 Jan-Feb |
|
Direct synthesis of peptides on convective interaction media monolithic columns for affinity chromatography. | 2002 Jan-Feb |
|
Three different bonding modes of cyano groups in the coordination polymer [Cu(en)2(H(2)O)][Cu(en)(2)Ni(2)Cu(2)(CN)(10)] x 2H(2)O (en is 1,2-diaminoethane). | 2002 Mar |
|
Designed self-assembly of molecular necklaces. | 2002 Mar 13 |
|
Role of magnesium in nucleotide exchange on the small G protein rac investigated using novel fluorescent Guanine nucleotide analogues. | 2002 Mar 19 |
|
[Ph(2)Bi-(Ge(9))-BiPh(2)](2-): a deltahedral Zintl ion functionalized by exo-bonded ligands. | 2002 Mar 20 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:33:06 GMT 2025
by
admin
on
Mon Mar 31 17:33:06 GMT 2025
|
Record UNII |
60V9STC53F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
||
|
EPA PESTICIDE CODE |
4205
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
||
|
CFR |
21 CFR 173.320
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4158
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | RxNorm | ||
|
7141
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
N0000171131
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
m5119
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB14189
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
CHEMBL816
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
3301
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
60V9STC53F
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
203-468-6
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
30347
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
SUB13760MIG
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
107-15-3
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
ETHYLENEDIAMINE
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
60V9STC53F
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
N0000184306
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
DTXSID5021881
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
C80898
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
100000092194
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
535
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
N0000175629
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SOLVATE->ANHYDROUS |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|